References
- C. A. Challener, "Chiral drugs", Aldershot, Ashgate Publishing, pp. 15-25, 2002.
- L. A. Nguyen, H. He, and C. Pham-Huy, "Chiral drugs, an overview", Int. J. Biomed. Sci., Vol. 2, pp. 85-100, 2006.
- G. Subramanian, "A practical approach to chiral separations by liquid chromatography", Weinheim, VCH, pp. 63-70, 1994.
- J. R. Brown, "Regulatory implications and chiral separations, In: A practical approach to chiral separations by liquid chromatography (Ed.: Subramanian, G.)", Weinheim, VCH, pp. 57-62. 1994,
- J. M. Daniels, E. R. Nestmann, and A. Kerr, "Development of stereoisomeric (chiral) drugs: a brief review of scientific and regulatory considerations", J. Drug Infor., Vol. 31, pp. 639-646, 1997. https://doi.org/10.1177/009286159703100303
- N. R. Srinivas, R. H. Barbhaiya, and K. K. Midha, "Enantiomeric drug development: issues, considerations, and regulatory requirements", J. Pharm. Sci., Vol. 90, pp. 1205-1215, 2001. https://doi.org/10.1002/jps.1074
- I. K. Reddy and R. Mehvar, "Chirality in drug design and development", Marcel Dekker, New York, pp. 419-432, 2004.
- FDA's policy statement for the development of new stereoisomeric drugs. Chirality, Vol. 4, pp. 338-340, 1992. https://doi.org/10.1002/chir.530040513
- FDA Drug guidances, "Development of new stereoisomeric drugs", July 6, 2005, Internet site : http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122883.htm
- Investigation of chiral active substances (CPMP/III/ 3501/91). Internet site: http://www.ema.europa.eu/ docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002816.pdf
- Guidance for Industry : Stereochemical Issues in Chiral Drug Development.Therapeutic Products Programme. Health Canada (May 1, 2000). Internet site: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/ applic-demande/guide-ld/chem/stereo-eng.php
- FDA Drug guidances: Development of new stereoisomeric drugs. (July 6, 2005), Internet site : http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122883.htm
- O. C. Sun, H. J. Sung, Y. U. So, J. J. Seo, I. K. Joo, and Y. C. Soo, "tereochemical Issues in Chiral Drug Development", J. Kor. Pharm. Sci., Vol. 35, pp. 57-63, 2005.
- 식품의약품안전청 공고 제 2008 - 82호, "의약품등의 품목허가신고심사규정", May 2, 2008, Internet site: http://kfda.go.kr/index.kfda?mid=54&seq=3742
- 의약품안전국, "K의약품등의 안전성유효성 심사 관련해설서", 식품의약품안전청, 2008.
- 미국 식품의약청 안전청 Internet site: http://www.fda.gov/Drugs/default.htm
- International Federation of Pharmaceutical Manufactures Associations; IFPMA internet site : www.ifpma.org
- Q6A International Conference on Harmonisation; Guidance on Q6A International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceutical Human Use, Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products : Chemical Substances, May, 2000, (CPMP/ICH/367/96) internet site: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC 500002823.pdf